相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion
Isabel Beerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313
Michael A. Pulsipher et al.
BLOOD (2009)
Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor
G. Bautista et al.
BONE MARROW TRANSPLANTATION (2009)
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation:: Higher CD34+ cell doses are associated with decreased relapse rates
Ryotaro Nakamura et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
Irving L. Weissman et al.
BLOOD (2008)
Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival
Yoshikane Kikushige et al.
JOURNAL OF IMMUNOLOGY (2008)
Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted
C Arber et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor
R Imamura et al.
JOURNAL OF IMMUNOLOGY (2005)
Cell intrinsic alterations underlie hematopoietic stem cell aging
DJ Rossi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CD34, CD49 and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies
TM Cao et al.
EXPERIMENTAL HEMATOLOGY (2005)
Differences between graft product and donor side effects following bone marrow or stem cell donation
G Favre et al.
BONE MARROW TRANSPLANTATION (2003)
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation
C Arber et al.
BLOOD (2003)
HLA-identical stem cell transplantation: is there an optimal CD34 cell dose?
S Heimfeld
BONE MARROW TRANSPLANTATION (2003)
Prospective isolation of human clonogenic common myeloid progenitors
MG Manz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S
TN Nakorn et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
JM Zaucha et al.
BLOOD (2001)
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
C Kollman et al.
BLOOD (2001)
Identification of a novel, human multilymphoid progenitor in cord blood
QL Hao et al.
BLOOD (2001)
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
WI Bensinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
